Deferred Tax Assets, Gross of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Gross for the quarter ending 31 Dec 2025 was $235,773,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $235,773,000 +$53,941,000 +30% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $0 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q4 2024 $181,832,000 +$45,071,000 +33% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $136,761,000 +$124,999,000 +1063% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $11,762,000 +$6,562,000 +126% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $5,200,000 -$69,779,000 -93% 31 Dec 2021 8-K 21 Dec 2023
Q4 2020 $74,979,000 +$21,158,000 +39% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q4 2019 $53,821,000 +$24,217,000 +82% 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q4 2018 $29,604,000 +$17,092,000 +137% 31 Dec 2018 10-K 03 Mar 2020 2019 FY
Q4 2017 $12,512,000 31 Dec 2017 10-K 19 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.